Pharmacy benefit management

With the updates to Medicare after the passing of the Affordable Care Act prescription drug cost is running rampant due to the inability to negotiate price and the lack of benchmarks for stability.

A “Hail Mary” pass is understandable when it comes to treating a seriously ill loved one, but questions remain about reimbursement.

The transaction sets up a showdown between Amazon and pharmacy benefit managers including Express Scripts, which recently agreed to be acquired by health insurer Cigna and CVS Health.

With the updates to Medicare after the passing of the Affordable Care Act prescription drug cost is running rampant due to the inability to negotiate price and the lack of benchmarks for stability.

Attempting to circumvent the costly specialty drug chain, brokers are encouraging clients to shop for FDA-approved drugs outside the U.S.

By continually reviewing prescription benefit policies and adapting them to current clinical information, employees are limited to their first exposure to addictive painkillers.

By passing this popular bipartisan legislation now, Congress can help make coverage and care more affordable for everyone.

By passing this popular bipartisan legislation now, Congress can help make coverage and care more affordable for everyone.

HHS' Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices.

A pharmacy benefit manager can often find true savings to critical drugs in the same neighborhood.

A pharmacy benefit manager can often find true savings to critical drugs in the same neighborhood.

The insurer’s 25% reduction in painkiller scripts nearly a year ahead of schedule sets new tone for managing national epidemic, catches large brokerage’s attention.

By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.

The insurer’s 25% reduction in painkiller scripts nearly a year ahead of schedule sets new tone for managing national epidemic, catches large brokerage’s attention.

As the Trump administration pledges to bring down America’s high-and-rising drug prices, workers are living with the burden of costly medications.

By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.

The president will propose a sweeping effort to bring down U.S. drug prices in a plan to make good on a campaign promise.

The price of prescriptions has skyrocketed and the industry needs to address matters sooner rather than later.

The price of prescriptions has skyrocketed and the industry needs to address matters sooner rather than later.

Many pharmacy benefit managers promote discounts and drug rebates that may look good on paper, but often provide no transparency of true costs. This can result in employers paying much more than they should.